Researchers used a genome-wide association study to identify seven loci associated with ASD and other conditions, along with five loci linked to ASD alone.
An international team of researchers used ancient and modern genome sequences to examine the admixture and population history of Finland.
In the Finnish GeneRisk study, patients at high risk for heart disease were especially motivated to take action if their polygenic risk score was high.
Along with a polygenic risk score enhanced in migraine sufferers, new research reveals a high-frequency variant implicated in cold adaptation and migraine in Europeans.
Researchers are working on RNA inference-based pesticides for crops, according to Digital Trends.
In PLOS this week: small bowel adenocarcinoma mutation signatures, omic analysis of M. tuberculosis strains, and more.
Amgen will use BC Platforms' tools and services to study data in multiple indications, including cardiovascular and bone diseases, hematological malignancies, and other cancers.
The project, dubbed FinnGen, was announced this week and is slated to run through mid-2023.
Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.
In PNAS this week: genome and transcriptome sequencing study of tobacco plants, molecular effects of cytochrome c oxidase mutations, and more.
Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.
A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.
At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.
In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.